Linzolid Suspension 100 mg/5 ml is a broad-spectrum oxazolidinone antibiotic formulated for oral administration, specifically designed for patients who have difficulty swallowing tablets, such as children and the elderly. It is effective against a range of serious Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE). Linzolid provides a reliable treatment option for complicated skin infections, pneumonia, and other systemic bacterial infections, ensuring flexibility in dosing and ease of administration.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

• Oxazolidinone Antibiotic

Pharmacology

Linezolid, the active ingredient, inhibits bacterial protein synthesis by binding to the 23S ribosomal RNA of the 50S subunit, preventing the formation of the 70S initiation complex. This mechanism is bacteriostatic against enterococci and staphylococci and bactericidal against most streptococci, providing potent action against resistant Gram-positive organisms.

The suspension has excellent oral bioavailability, ensuring systemic efficacy comparable to tablets. Linezolid distributes widely into tissues, including lungs, skin, and soft tissues, making it suitable for systemic infections. Minimal hepatic metabolism occurs, and most of the drug is excreted in urine as metabolites, with a plasma half-life of 5–7 hours.

Indications

Linzolid Suspension 100 mg/5 ml is indicated for:

• Complicated skin and soft tissue infections caused by susceptible Gram-positive bacteria

• Nosocomial and community-acquired pneumonia

• MRSA and VRE infections where other antibiotics are ineffective or contraindicated

• Pediatric bacterial infections requiring oral therapy

Dosage and Administration

• Children (6–12 years): 10 mg/kg every 8–12 hours as prescribed by a physician

• Adults: Typically, 600 mg (equivalent volume of suspension) every 12 hours

• Duration: Usually 10–14 days, depending on infection type and severity

• Administration: Shake well before use. Measure accurately using a calibrated dosing syringe or cup. Can be taken with or without food for optimal absorption

Contraindications

• Hypersensitivity to Linezolid or any component of the formulation

• Concurrent use with monoamine oxidase inhibitors (MAOIs) due to the risk of serotonin syndrome

• History of linezolid-induced myelosuppression

Side Effects

Linzolid Suspension is generally well tolerated, but potential side effects may include:

• Hematologic: Thrombocytopenia, anemia, leukopenia, and pancytopenia, especially with prolonged therapy

• Gastrointestinal: Nausea, vomiting, diarrhea, and taste disturbances

• Neurological: Headache, dizziness, peripheral neuropathy (rare with long-term use)

• Other: Rare occurrences of lactic acidosis or optic neuropathy with extended use

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Monitor blood counts during therapy, particularly for courses longer than 2 weeks

• Use cautiously in patients with renal or hepatic impairment

• Avoid foods high in tyramine and certain medications to prevent hypertensive reactions or serotonin syndrome

• Pregnancy & Lactation: Use only if clearly necessary. Excretion in breast milk occurs; breastfeeding should be avoided during treatment

Storage Conditions

• Store in a cool, dry place below 30°C, protected from light and moisture

• Shake well before each use

• Keep out of reach of children

Mode of Action

Linzolid Suspension 100 mg/5 ml delivers targeted inhibition of bacterial protein synthesis, effectively controlling resistant Gram-positive infections. Its oral suspension form provides flexibility for pediatric and adult patients unable to swallow tablets, ensuring consistent therapeutic outcomes.